SEC Form 4 · accession 0000884731-16-000085
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paris Panayiotopoulos
Officer — President and CEO · Director
Period of report
Jul 13, 2016
Accepted (ET)
Jul 14, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 13, 2016 | M | 66,600 | $0.00 | A | 154,689 | D | |
| Common StockF2 | Jul 13, 2016 | F | 28,611 | $7.14 | D | 126,078 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F4 | $0.00 | Jul 13, 2016 | M | 66,600 | D | — | — | Common Stock | 66,600 | 133,400 | D |
Explanation of responses
- F1Shares were acquired upon the vesting of a Restricted Stock Unit (RSU) dated January 13, 2016.
- F2Represents shares withheld to satisfy withholding tax requirements as approved in advance by the Board of Directors of the Company in accordance with Rule 16b-3(e).
- F3These RSUs vest as to one third of the award on each of July 13, 2016, January 13, 2017 and July 13, 2017.
- F4N/A